| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.039 | 0.3 |